Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 Jan:54:200-209.
doi: 10.1016/j.ejpn.2025.02.004. Epub 2025 Feb 11.

The natural history of pediatric Sturge-Weber Syndrome: A multinational cross-sectional study

Sigrid Claudia Disse  1 , Hanna Küpper  2 , Annette Bock  3 , Georg-Christoph Korenke  4 , Georgia Ramantani  5 , Birgit Weidner  6 , Martin Preisel  7 , Regina Trollmann  8 , Adelheid Wiemer-Kruel  9 , Knut Brockmann  10 , Simone Schroeder  11 , Sascha Meyer  12
Affiliations
Free article
Observational Study

The natural history of pediatric Sturge-Weber Syndrome: A multinational cross-sectional study

Sigrid Claudia Disse et al. Eur J Paediatr Neurol. 2025 Jan.
Free article

Abstract

Background: Sturge-Weber Syndrome (SWS) is a capillary-venous malformation which includes the brain (leptomeningeal venous capillary malformation), the eye (choroidal angioma) and the skin (facial portwine birthmark, FPB). Structural epilepsy, glaucoma and FPBs pose therapeutic challenges. Considerable advances include improved neuroimaging, new antiseizure medication (ASM) and progress in epilepsy surgery. Yet, comprehensive data on epidemiology, clinical features, diagnostics, and treatment in contemporary pediatric SWS cohorts is scarce.

Methods: We conducted a multinational cross-sectional observational study in Germany, Switzerland and Austria to identify potential patients and build up a comprehensive database containing anonymized patient data. The patients' guardians and child neurologists filled in detailed questionnaires on histories, clinical features, diagnostic and therapeutic measures.

Results: Forty-seven SWS patients from Germany, Switzerland or Austria participated in our survey (111 notifications, i.e. the participation rate was 43 %). Prevalence was 7.37/million in Germany, 4.60/million in Switzerland, 2.61/million in Austria. Severity of skin, eye and brain involvement varied highly. Forty-three patients (91 %) were diagnosed with epilepsy. Median age at first seizure was 6.5 months. Thirty-two percent of the cohort received ASM in monotherapy, fifty-three percent received combination therapy and thirteen percent received no ASM. Eight percent underwent epilepsy surgery.

Conclusions: In this European pediatric SWS cohort from a well-established tertiary child neurologist network, the condition was commonly diagnosed within the first year of life. 40 % of the cohort were seizure-free at inclusion; only 8.5 % of the cohort underwent epilepsy surgery. Our findings are concordant with published data from U.S. registries and case series. While our results indicate diagnostic improvement as compared to published studies, epilepsy management in SWS remains a challenge.

Keywords: ESNEK; Observational study; Pediatric study; Phacomatosis; Sturge-Weber Syndrome.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest Interim results of this study were presented at a Meeting of the German National Sturge-Weber Foundation (IG, “Interessensgemeinschaft” SWS) in Herbstein/Germany in 2019. The main study findings were presented at the German Pediatric National conference as a poster in 2020. All authors confirm that they have no conflicting interests.

Publication types